Stock listing
NASDAQ:ENLV Enlivex Ltd. Stock
Home listing (NASDAQ) of Enlivex Ltd.
Follow Enlivex Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:ENLV
$1.78 USD -0.76 (-29.9%)
Close on Oct 30, 2026
- Day range
- $1.73 – $2.47 USDOct 30, 2026
- Volume
- 128,200 sharesOct 30, 2026
- Market cap
- $2.73M USDAt the close on Oct 30, 2026 · price × 1.53M shares outstanding
- 52-week range
- $0.17 – $27.14 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $37,513 USDMedian day 25,600 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENLV · Home | $1.78 USD | -0.76 (-29.9%) | 128,200 | $2.47 | $2.47 | $1.73 | $2.54 | Close on Oct 30, 2026 |
| Frankfurt:1BT | €2.20 EUR | +2.045 (+1319.4%) | — | €2.20 | €2.20 | €2.20 | €0.155 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ENLV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.78 | -0.76 | -29.9% | $2.47 | $2.47 | $1.73 | 128,200 | |
| $2.54 | -0.07 | -2.7% | $2.62 | $2.76 | $2.46 | 49,800 | |
| $2.61 | +2.437 | +1408.7% | $2.71 | $2.765 | $2.55 | 36,000 | |
| $0.173 | +0.00 | +0.1% | $0.173 | $0.173 | $0.173 | 79,959 | |
| $0.173 | 0.00 | 0.0% | $0.173 | $0.173 | $0.173 | 1,553 | |
| $0.173 | -0.026 | -12.9% | $0.17 | $0.182 | $0.17 | 40,944 | |
| $0.198 | -0.003 | -1.6% | $0.197 | $0.205 | $0.192 | 32,819 | |
| $0.202 | -0.022 | -10.0% | $0.222 | $0.23 | $0.20 | 46,394 | |
| $0.224 | +0.018 | +8.5% | $0.214 | $0.229 | $0.205 | 27,969 | |
| $0.206 | +0.002 | +0.8% | $0.211 | $0.227 | $0.194 | 37,900 | |
| $0.205 | -0.019 | -8.6% | $0.23 | $0.234 | $0.205 | 29,981 | |
| $0.224 | +0.008 | +3.7% | $0.221 | $0.237 | $0.21 | 34,863 | |
| $0.216 | -0.006 | -2.9% | $0.226 | $0.229 | $0.21 | 34,800 | |
| $0.222 | -0.03 | -12.0% | $0.259 | $0.261 | $0.221 | 54,275 | |
| $0.253 | -0.002 | -0.6% | $0.261 | $0.262 | $0.245 | 55,806 | |
| $0.254 | -0.022 | -8.1% | $0.25 | $0.283 | $0.224 | 173,988 | |
| $0.277 | -0.029 | -9.4% | $0.333 | $0.43 | $0.254 | 2,042,550 | |
| $0.306 | -0.035 | -10.3% | $0.352 | $0.352 | $0.301 | 243,675 | |
| $0.341 | -0.021 | -5.8% | $0.374 | $0.378 | $0.341 | 25,581 | |
| $0.362 | -0.026 | -6.6% | $0.40 | $0.408 | $0.362 | 26,450 | |
| $0.387 | -0.035 | -8.3% | $0.424 | $0.43 | $0.381 | 39,444 | |
| $0.422 | -0.08 | -15.9% | $0.493 | $0.502 | $0.411 | 47,194 | |
| $0.502 | +0.022 | +4.7% | $0.482 | $0.581 | $0.47 | 60,544 | |
| $0.48 | -0.034 | -6.5% | $0.52 | $0.53 | $0.47 | 36,613 | |
| $0.514 | -0.085 | -14.2% | $0.60 | $0.60 | $0.502 | 39,438 | |
| $0.598 | -0.008 | -1.3% | $0.60 | $0.621 | $0.581 | 19,750 | |
| $0.606 | -0.034 | -5.2% | $0.634 | $0.64 | $0.57 | 23,563 | |
| $0.64 | -0.006 | -1.0% | $0.634 | $0.686 | $0.614 | 37,100 | |
| $0.646 | -0.046 | -6.7% | $0.69 | $0.709 | $0.574 | 77,025 | |
| $0.693 | -0.114 | -14.1% | $0.84 | $0.85 | $0.666 | 41,800 | |
| $0.806 | +0.08 | +11.0% | $0.73 | $0.819 | $0.71 | 21,869 | |
| $0.726 | -0.085 | -10.5% | $0.821 | $0.851 | $0.64 | 47,625 | |
| $0.811 | -0.072 | -8.2% | $0.901 | $0.92 | $0.79 | 25,619 | |
| $0.883 | +0.018 | +2.0% | $0.88 | $0.92 | $0.87 | 14,338 | |
| $0.866 | -0.094 | -9.8% | $0.95 | $1.021 | $0.864 | 19,019 | |
| $0.96 | -0.021 | -2.1% | $1.00 | $1.07 | $0.95 | 15,394 | |
| $0.981 | -0.059 | -5.7% | $1.03 | $1.061 | $0.981 | 17,406 | |
| $1.04 | -0.07 | -6.3% | $1.12 | $1.218 | $1.021 | 17,950 | |
| $1.11 | +0.01 | +0.9% | $1.101 | $1.19 | $1.061 | 11,856 | |
| $1.101 | -0.059 | -5.1% | $1.15 | $1.16 | $1.021 | 15,694 | |
| $1.16 | -0.09 | -7.2% | $1.25 | $1.275 | $1.13 | 18,375 | |
| $1.25 | -0.03 | -2.4% | $1.29 | $1.301 | $1.21 | 14,219 | |
| $1.28 | 0.00 | 0.0% | $1.27 | $1.31 | $1.20 | 21,456 | |
| $1.28 | -0.07 | -5.2% | $1.33 | $1.341 | $1.15 | 25,006 | |
| $1.35 | -0.125 | -8.5% | $1.501 | $1.574 | $1.346 | 33,206 | |
| $1.475 | -0.04 | -2.6% | $1.51 | $1.661 | $1.47 | 32,338 | |
| $1.515 | -0.005 | -0.3% | $1.52 | $1.621 | $1.461 | 9,331 | |
| $1.52 | +0.01 | +0.6% | $1.49 | $1.57 | $1.461 | 10,100 | |
| $1.51 | +0.04 | +2.7% | $1.48 | $1.56 | $1.44 | 8,988 | |
| $1.47 | -0.03 | -2.0% | $1.49 | $1.52 | $1.39 | 9,675 | |
| $1.501 | -0.229 | -13.2% | $1.68 | $1.701 | $1.454 | 16,931 | |
| $1.73 | +0.21 | +13.8% | $1.501 | $1.81 | $1.47 | 18,444 | |
| $1.52 | -0.061 | -3.8% | $1.57 | $1.581 | $1.48 | 9,250 | |
| $1.581 | 0.00 | 0.0% | $1.59 | $1.621 | $1.541 | 10,913 | |
| $1.581 | -0.109 | -6.4% | $1.71 | $1.71 | $1.53 | 21,388 | |
| $1.69 | -0.15 | -8.2% | $1.941 | $1.981 | $1.68 | 28,225 | |
| $1.84 | -0.08 | -4.2% | $2.00 | $2.181 | $1.72 | 40,250 | |
| $1.92 | -0.09 | -4.5% | $2.021 | $2.094 | $1.89 | 11,581 | |
| $2.01 | -0.07 | -3.4% | $2.021 | $2.13 | $1.946 | 11,894 | |
| $2.08 | +0.099 | +5.0% | $1.981 | $2.138 | $1.901 | 12,625 | |
| $1.981 | -0.20 | -9.2% | $2.15 | $2.19 | $1.92 | 12,688 | |
| $2.181 | +0.07 | +3.3% | $2.07 | $2.261 | $1.981 | 17,919 | |
| $2.11 | -0.059 | -2.7% | $2.25 | $2.254 | $2.03 | 29,213 | |
| $2.17 | +0.08 | +3.8% | $2.141 | $2.323 | $2.11 | 17,081 | |
| $2.09 | +0.139 | +7.1% | $1.91 | $2.16 | $1.80 | 21,369 | |
| $1.95 | -0.299 | -13.3% | $2.25 | $2.25 | $1.92 | 19,663 |
- Ticker
- NASDAQ:ENLV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Latest deck · Jun 24, 2026
Investor Presentation (June 2026)
Investor deck · 25 slides
Latest news
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Oct 28, 2026
Closed $2.61 (+1408.7%) on Oct 28, 2026
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Oct 27, 2026
Closed $0.173 (+0.1%) on Oct 27, 2026
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
Oct 22, 2026
Closed $0.173 (-12.9%) on Oct 23, 2026
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
Sep 22, 2026
Closed $0.646 (-6.7%) on Sep 22, 2026
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
Jul 30, 2026
Closed $1.95 (-13.3%) on Jul 30, 2026
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
Jul 29, 2026
Closed $2.25 (+0.4%) on Jul 29, 2026
Enlivex Announces $400,000,000 Private Placement
Jul 28, 2026
Closed $2.24 (-47.4%) on Jul 28, 2026
Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
Jul 20, 2026
Closed $4.64 (-0.9%) on Jul 20, 2026
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
Jul 13, 2026
Closed $6.67 (-2.8%) on Jul 13, 2026
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
Jul 7, 2026
Closed $7.42 (-3.4%) on Jul 7, 2026
Financings
Private placement of ordinary shares
Sep 22, 2026
Cancelled: US$400M · US$6 a share
Buyers: Rain Foundation (66,666,667 ordinary shares, to be paid for using RAIN tokens (agreement terminated))
Use of proceeds: Treasury strategy built around the Rain protocol prediction markets, while continuing to advance its Allocetra immunotherapy for age-related osteoarthritis
Decks
Investor Presentation (June 2026)
Investor deck · 25 slides · Jun 24, 2026
Investor Presentation (June 2026)
Investor deck · 35 slides · June 2026
Investor Presentation (March 2026)
Investor deck · 26 slides · Mar 24, 2026
Enlivex Therapeutics — Investor Presentation (November 2025)
Investor deck · 26 slides · Nov 24, 2025
Enlivex Ltd. on 6ix
- News releases
- 34 in the last 12 months · 148 in all · newest Oct 28, 2026 · oldest 2019
- Decks
- 32 decks · latest Jun 24, 2026
Where Enlivex Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENLV · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A119KH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A119KH | Lang & Schwarz | Germany | EUR |
| Frankfurt:1BT | Frankfurt | Germany | EUR |
| Tradegate:1BT | Tradegate | Germany | EUR |
| BOATS:ENLV | BOATS | United States | USD |
| Stuttgart:1BT | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Enlivex Ltd.